Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 43.14%-4.06B | ---- | -952.75%-7.14B | ---- | 152.29%836.97M | ---- | -189.89%-1.6B | ---- | 93.65%1.78B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 15.57%-204.04M | ---- | 23.91%-241.68M | ---- | 8.26%-317.62M | ---- | -9.30%-346.24M | ---- | -133.32%-316.79M |
| Interest expense - adjustment | ---- | ---- | ---- | ---- | ---- | 23.41%418.53M | ---- | -16.61%339.13M | ---- | -34.97%406.69M |
| Investment loss (gain) | ---- | -53.10%3.23B | ---- | 321.26%6.89B | ---- | -59.94%1.63B | ---- | 2,181.97%4.08B | ---- | -224.84%-196.04M |
| Attributable subsidiary (profit) loss | ---- | 1,566.04%485.25M | ---- | 106.73%29.13M | ---- | -1,548.93%-432.85M | ---- | -932.25%-26.25M | ---- | -103.24%-2.54M |
| Revaluation surplus: | ---- | 1,233.73%633.36M | ---- | 93.01%-55.87M | ---- | -61.61%-799.27M | ---- | -304.61%-494.57M | ---- | 91.91%241.72M |
| -Fair value of investment properties (increase) | ---- | 1,233.73%633.36M | ---- | 93.01%-55.87M | ---- | -61.61%-799.27M | ---- | -304.61%-494.57M | ---- | 91.91%241.72M |
| Asset sale loss (gain): | ---- | 252.73%194K | ---- | --55K | ---- | ---- | ---- | -84.55%34K | ---- | -51.86%220K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 252.73%194K | ---- | --55K | ---- | ---- | ---- | -84.55%34K | ---- | -51.86%220K |
| Depreciation and amortization: | ---- | -2.10%212.21M | ---- | -2.66%216.77M | ---- | -0.65%222.71M | ---- | 9.94%224.16M | ---- | -6.35%203.9M |
| -Depreciation | ---- | -2.10%212.21M | ---- | -2.66%216.77M | ---- | -0.65%222.71M | ---- | 9.94%224.16M | ---- | -6.35%203.9M |
| Financial expense | ---- | 2.31%619.14M | ---- | --605.17M | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items | ---- | -86.23%121.92M | ---- | --885.21M | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | ---- | -12.49%1.04B | ---- | -23.96%1.19B | ---- | -28.19%1.56B | ---- | 2.81%2.18B | ---- | 6.49%2.12B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -1.84%1.17M | ---- | 111.88%1.2M | ---- | -1,613.98%-10.07M | ---- | -58.39%665K | ---- | 8.63%1.6M |
| Developing property (increase)decrease | ---- | ---- | ---- | ---- | ---- | -2.23%-710.94M | ---- | 70.57%-695.42M | ---- | -17,911.22%-2.36B |
| Accounts receivable (increase)decrease | ---- | 43.33%-482.41M | ---- | 26.02%-851.33M | ---- | -104.30%-1.15B | ---- | -2,459.28%-563.25M | ---- | 113.77%23.87M |
| Accounts payable increase (decrease) | ---- | -188.74%-98.97M | ---- | 902.48%111.52M | ---- | 98.70%-13.9M | ---- | -199.83%-1.07B | ---- | 9,371.04%1.07B |
| Special items for working capital changes | ---- | 638.65%2.56B | ---- | -126.46%-475.68M | ---- | 852.73%1.8B | ---- | -89.65%188.71M | ---- | 270.43%1.82B |
| Cash from business operations | 113.11%2.59B | 11,963.53%3.02B | 1,192.72%1.22B | -101.73%-25.48M | -502.49%-111.28M | 4,090.23%1.48B | 105.15%27.65M | -98.69%35.22M | -148.40%-537.35M | 271.12%2.68B |
| Other taxs | ---- | -2,503.37%-80.42M | -11,847.14%-83.63M | -2.22%-3.09M | 69.42%-700K | 41.81%-3.02M | -341.89%-2.29M | -6,473.42%-5.19M | -360.30%-518K | 99.51%-79K |
| Interest received - operating | -77.94%35.69M | -9.49%306.44M | 8.94%161.81M | 1,272.30%338.59M | 1,481.27%148.53M | 18.19%24.67M | 39.13%9.39M | 265.01%20.88M | -74.72%6.75M | -76.85%5.72M |
| Interest paid - operating | 47.10%-293.79M | 5.52%-1.06B | -11.11%-555.4M | -92.93%-1.12B | -95.67%-499.89M | -20.87%-580.71M | 3.33%-255.48M | -12.49%-480.45M | -21.90%-264.28M | 31.80%-427.11M |
| Net cash from operations | 215.83%2.33B | 370.26%2.19B | 259.45%738.8M | -188.40%-810.32M | -109.92%-463.35M | 313.39%916.62M | 72.25%-220.73M | -119.03%-429.55M | -186.43%-795.4M | 2,065.08%2.26B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --7.56M | ---- | ---- |
| Restricted cash (increase) decrease | --11.87M | ---282.61M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Loan receivable (increase) decrease | 105.84%22.18M | -1.45%-494.35M | -39.03%-379.56M | ---487.27M | -81.53%-273M | ---- | -201.96%-150.39M | 312.43%266.51M | 731.17%147.51M | 107.43%64.62M |
| Purchase of fixed assets | 56.39%-13.7M | -13.56%-52.32M | -130.58%-31.41M | 15.26%-46.07M | 58.52%-13.62M | 80.31%-54.36M | 83.81%-32.84M | -198.20%-276.14M | -525.78%-202.8M | -31.56%-92.6M |
| Sale of subsidiaries | ---- | ---- | ---- | ---379K | ---379K | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | -81.30%17.26M | -20.02%95.36M | -26.56%92.31M | -58.86%119.23M | 2,248.16%125.69M | 209.19%289.84M | ---5.85M | ---265.46M | ---- | ---- |
| Cash on investment | 26.68%-841K | ---- | 77.66%-1.15M | 83.93%-306K | 46.47%-5.13M | 94.74%-1.9M | 96.51%-9.59M | -59.65%-36.2M | -3,716.22%-274.81M | 96.65%-22.68M |
| Other items in the investment business | ---- | 72.75%382.36M | ---- | 201.53%221.34M | ---- | ---218.02M | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 111.50%36.77M | -81.72%-351.55M | -92.14%-319.81M | -1,343.42%-193.45M | 16.22%-166.45M | 105.12%15.56M | 39.82%-198.67M | -499.55%-303.73M | -424.15%-330.11M | 96.70%-50.66M |
| Net cash before financing | 465.69%2.37B | 283.15%1.84B | 166.53%418.99M | -207.68%-1B | -50.17%-629.79M | 227.12%932.18M | 62.74%-419.4M | -133.23%-733.29M | -231.29%-1.13B | 254.15%2.21B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -82.57%345M | -32.39%2.99B | -4.24%1.98B | 27.89%4.42B | 0.91%2.07B | -15.65%3.46B | -39.42%2.05B | 146.67%4.1B | 37,456.38%3.38B | -35.68%1.66B |
| Refund | 41.59%-1.56B | -48.14%-4.93B | -99.86%-2.67B | 21.39%-3.33B | 16.54%-1.33B | 6.42%-4.23B | 39.05%-1.6B | -81.01%-4.52B | -470.63%-2.62B | -272.98%-2.5B |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---53.75M | ---75.18M | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -150.00%-250M |
| Other items of the financing business | -59.25%1.21M | -634.87%-19.07M | 161.13%2.97M | -17.13%3.57M | -37.87%1.14M | 114.35%4.3M | 44.55%1.83M | -5.73%2.01M | 48.07%1.27M | -59.72%2.13M |
| Net cash from financing operations | -76.30%-1.21B | -280.20%-1.96B | -194.26%-687.67M | 239.88%1.09B | 63.35%729.52M | -62.33%-779.47M | -34.58%446.6M | 55.85%-480.17M | 197.38%682.63M | -161.10%-1.09B |
| Effect of rate | -747.79%-7.17M | -267.99%-19.31M | 111.93%1.11M | -64.31%-5.25M | 57.33%-9.28M | -149.24%-3.19M | -939.03%-21.75M | -67.87%6.49M | -134.23%-2.09M | 526.60%20.19M |
| Net Cash | 530.93%1.16B | -246.04%-126.45M | -369.42%-268.68M | -43.30%86.58M | 266.62%99.72M | 112.58%152.7M | 106.14%27.2M | -208.44%-1.21B | -383.40%-442.87M | 220.95%1.12B |
| Begining period cash | -13.10%966.6M | 7.89%1.11B | 7.89%1.11B | 16.96%1.03B | 16.96%1.03B | -57.79%881.52M | -57.79%881.52M | 120.01%2.09B | 120.01%2.09B | 56.81%949.28M |
| Cash at the end | 150.62%2.12B | -13.10%966.6M | -24.67%844.79M | 7.89%1.11B | 26.44%1.12B | 16.96%1.03B | -46.03%886.97M | -57.79%881.52M | 47.84%1.64B | 120.01%2.09B |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unaudited opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.